Clinical relevance of Proteus mirabilis in hospital patients: a two year survey | Zendy

Christophe de Champs | Zendy; Richard Bonnet | Zendy; D. Sirot | Zendy; C. Chanal | Zendy; J. Sirot | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical relevance of Proteus mirabilis in hospital patients: a two year survey

Author(s) -

Christophe de Champs,

Richard Bonnet,

D. Sirot,

C. Chanal,

J. Sirot

Publication year - 2000

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/45.4.537

Subject(s) - proteus mirabilis , microbiology and biotechnology , enterobacteriaceae , medicine , intensive care , proteus infections , proteus , biology , bacteria , intensive care medicine , escherichia coli , pseudomonas aeruginosa , biochemistry , genetics , gene

A retrospective study was performed on 1072 non-duplicate isolates of Proteus mirabilis, taken in the period April 1996 to March 1998, and on 100 patient charts randomly selected during the same period. P. mirabilis isolates accounted for 7.7% of Enterobacteriaceae. The isolates were predominantly from urine (70.2%); of the total, 38.0% were penicillinase-producing isolates, 6.9% were extended-spectrum beta-lactamase (ESBL)-producing isolates and 3.6% produced inhibitor-resistant beta-lactamase (IRB). ESBL-producing isolates were observed in long-stay and intensive care and IRB-producing isolates in paediatric units. Of the 95 patients whose charts were examined, 69 had a confirmed infection, which in 42 cases was nosocomial.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research